| Type 2 Diabetes Mellitus |
1 |
1 |
| Child |
0 |
0.9 |
| Hypertension |
0 |
0.58 |
| Adolescent Medicine |
0 |
0.95 |
| Lipids Management |
0 |
0.46 |
| Heart Failure (HF) |
0 |
0.44 |
| Social Determinants of Health |
0 |
0.44 |
| Renal Failure |
0 |
0.39 |
| Health Care Quality, Access, and Evaluation |
0 |
0.37 |
| Myocardial Infarction (MI) |
0 |
0.36 |
| Retinal Diseases |
0 |
0.35 |
| Coronary Artery Disease (CAD) |
0 |
0.33 |
| Dyslipidemia |
0 |
0.28 |
| Heart |
0 |
0.28 |
| Biologic Therapy |
0 |
0.18 |
| Colorado |
0 |
0.18 |
| Infarction |
0 |
0.18 |
| Medicaid |
0 |
0.18 |
| Renal Disease |
0 |
0.18 |
| Stress |
0 |
0.18 |
| Overdose |
0 |
0.16 |
| Addiction |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.15 |
| Macular Edema |
0 |
0.13 |
| Artery |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Cerebrovascular Accident |
0 |
0.09 |
| Edema |
0 |
0.09 |
| Exercise |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Health Care Economics |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Insulin Resistance |
0 |
0.09 |
| Insurance |
0 |
0.09 |
| Jobs |
0 |
0.09 |
| Nerve |
0 |
0.09 |
| Neuropathy |
0 |
0.09 |
| Orbit |
0 |
0.09 |
| Polypharmacy |
0 |
0.09 |
| Retinopathy |
0 |
0.09 |
| Sepsis |
0 |
0.09 |
| Translational Research |
0 |
0.09 |
| Uninsured |
0 |
0.09 |
| Young Adult |
0 |
0.09 |